Quentis Therapeutics says it has raised $48 million from venture capitalists to develop drugs that unleash the immune system against cancer.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2018/02/27/new-york-firm-raises-48-million-to-develop-new-cancer-immunotherapies/
via IFTTT
No comments:
Post a Comment